Evidence map›Paper›PMID 41079395›Full record

ReviewFrontiers in toxicology2025

Forensic toxicology of benzodiazepines: neuropharmacological effects, analytical challenges, and emerging detection strategies.

Husna Irfan Thalib, Ahmed Abdelghany Damanhory, Ayesha Hanin Shaikh, Shyma Haidar, Sariya Khan, Ayesha Jamal, Omar Ahmed Abdelghany

Abstract readReview
In one paragraph

Review in Frontiers in toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Husna Irfan ThalibGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Ahmed Abdelghany DamanhoryDepartment of Biochemistry, General Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Ayesha Hanin ShaikhGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Shyma HaidarGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Sariya KhanGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Ayesha JamalGeneral Medicine Practice Program, Batterjee Medical College, Jeddah, Saudi Arabia.
Omar Ahmed AbdelghanyKasr Al-Ainy, Faculty of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing misuse of benzodiazepines (BZDs) in drug-facilitated crimes (DFCs) has become a serious concern for forensic experts, healthcare professionals, and legal authorities. These drugs, which are commonly prescribed for anxiety and sleep disorders, are also used to commit crimes such as sexual assault and robbery. Their sedative and memory-blocking effects render them particularly dangerous. One of the biggest challenges is that BZDs are rapidly broken down in the body, limiting the time available for detection. This creates major problems in forensic investigations and reduces the chance of holding offenders accountable for their actions. In addition, memory loss caused by BZDs often affects a victim's ability to recall events, making legal cases more challenging. This review aims to comprehensively synthesize the current knowledge on the use of BZDs in DFCs, their neuropharmacological mechanisms, and the challenges associated with their detection. It also discusses legal issues and emerging forensic tools that may help overcome the current limitations. By addressing this issue from medical, forensic, and legal perspectives, this review aims to recommend better prevention strategies, more effective investigations, and stronger legal outcomes for cases involving benzodiazepine-facilitated crimes.

Indexed as

benzodiazepines (BZDS)cognitive impairmentdrug-facilitated crimes (DFCS)forensic detectionlegal challenges

Identifiers

PMID41079395
PMCPMC12507772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.